Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia
Key facts
- Who runs it
- Medical University of Vienna
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- Jun 2014
- Expected to end
- Jun 2027
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Endoscopic intervention A
- Endoscopic intervention B
- Endoscopic intervention C
- Laparoscopic Surgery
- Record updated
- 10 August 2015
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Confirmed diagnosis of achalsia, hypertensive lower esophageal sphincter, nutcracker esophagus, or diffuse esophageal spasm
Who cannot take part
- Contraindication for EGD
This trial is currently available in Austria.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Achalasia is an esophageal motility disorder, which leads to clinical symptoms such as dysphagia, regurgitation, chest pain and consecutive weight loss.
Read full original descriptionShow less
Although conventional treatment such as laparoscopic Heller myotomy (LHM) and balloon dilatation (BD) can provide sufficient symptom relief in many patients, both interventions have their individual drawbacks. Additionally, treatment after failed LHM or BD can be challenging and in few might even lead to esophagectomy.
Per oral endoscopic myotomy (POEM) and prolonged dilatation (PRD) are two novel endoscopically performed therapeutic options for achalasia and other esophageal motility disorders. Both not only appear to provide good results, when performed as initial treatment but also might be an excellent option after e.g failed LHM.
The purpose of this study is to evaluate the long-term efficacy of four different treatment options, such as POEM, PRD with stent-fixation, PD and conventional LHM for achalasia in an individualized treatment setting.
The 4 groups in the trial
- Per oral endoscopic therapy AExisting treatment, for comparison
Per oral endoscopic myotomy
Treatment: Endoscopic intervention A
- Per oral endoscopic therapy BExisting treatment, for comparison
Prolonged dilatation by implantation of large diameter stents.
Treatment: Endoscopic intervention B
- Per oral endoscopic therapy CExisting treatment, for comparison
Dilatation
Treatment: Endoscopic intervention C
- Laparoscopic surgeryExisting treatment, for comparison
Laparoscopic Heller myotomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) as Additional Endoscopic Treatment Options for Achalasia and Other Esophageal Motility Disorders
- Record updated
- 10 August 2015